Home/Publication/Chengwei & HSG Re-up in Oncology Treatment
Chengwei & HSG Re-up in Oncology Treatment 

02 Oct 2025

US$ 20.00

China-based Chengwei Capital and HongShan Capital Group have made a follow-on investment in the US$77 m raised by ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly ending 3 Oct 2025...

Brookfield Asset Management Ltd has raised over US$4 bn for the initial closing of Brookfield Infrastructure Debt ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.